Person:
RABUŞ, ŞULE

Profile Picture

Email Address

Birth Date

Research Projects

Organizational Units

OrgUnit Logo
Organizational Unit

Job Title

Last Name

RABUŞ

First Name

ŞULE

Name

Filters

2016 - 201912020 - 20222
Reset filters

Settings

Start date: 2010 × Has files: true ×

Search Results

Now showing 1 - 3 of 3
  • Thumbnail Image
    PublicationOpen Access
    Evaluation of awareness and knowledge of antibiotic use of patients applying to a community pharmacy
    (2022-06-01) RABUŞ, ŞULE; Tezcan S., Bilgin S., Sari H., Apikoglu-Rabus S.
    Background and Objective: Infectious diseases constitute a large share of the diseases in the world. The use of irrational antimicrobial treatments causes failure in the treatment and toxic side effects in the patient.The aim of our study is to evaluate the knowledge level and attitudes of the patients who applied to the community pharmacy with an antibiotic prescription regarding the use of antibiotics. Setting and Method: This cross-sectional study was conducted in one community pharmacy in Istanbul (Turkey) between November 2021- February 2022. Each patient’s profile was recorded and a selfstructured questionnaire consisted 14 questions was administered to the patients who applied to the pharmacy with an antibiotic prescription. The questionnaire, which was prepared by the researchers on the basis of the relevant literature studies (1,2) and the answer options were determined as ‘‘true, false, I do not know’’. The questionnaire results were scored according to the relevant articles. All data were analyzed using the Statistical Package for the Social Sciences (SPSS Inc., Chicago, IL, USA) version 13. Main outcome measures: To evaluate the knowledge level and attitudes of the patients regarding the use of antibiotics. Results: Of the 39 patients 66.7% were female, and the mean age was 35.2 ± 1.6. Sixty-one percent of the patients were not working in any job. The majority of the patients (79.5%) applied to the pharmacy with the diagnosis of upper respiratory tract disease. The mean awareness score of the patients regarding the use of antibiotics was determined as 7.8 ± 0.4, and it was found to be higher in those who were actively employed than in those who did not (8.8 ± 0.5 vs. 7.1 ± 0.4; p = 0.022). It was determined that 77% of the patients had a moderate level of knowledge about antibiotics. Conclusion: According to the results of the study, awareness, and knowledge regarding the use of antibiotics were insufficient. Community pharmacists as specialist health professionals have a vital role in the rational use of antibiotics via patient education and monitoring. References: 1. Ling Oh A, Hassali MA, Al-Haddad MS, Syed Sulaiman SA, Shafie AA, Awaisu A. Public knowledge and attitudes towards antibiotic usage: a cross-sectional study among the general public in the state of Penang, Malaysia. J Infect Dev Ctries. 2011;5(5):338–347. Published 2011 May 28. doi:10. 3855/jidc.1502 2. Zaidi SF, Baroom MW, Ibrahim Hanbashi A, et al. Cross-Sectional Survey among General Population Regarding Knowledge and Attitude toward Antibiotic Usage in Western Saudi Arabia. Pharmacy (Basel). 2021;9(2):98. Published 2021 May 1. doi:10. 3390/pharmacy9020098 Disclosure of Interest: None Declared.
  • Thumbnail Image
    PublicationOpen Access
    Evaluation of attitudes of patients regarding vaccine hesitancy during COVID-19: community pharmacy setting
    (2022-06-01) RABUŞ, ŞULE; Tezcan S., Koc G., Sari H., Apikoglu-Rabus S.
    Background and Objective: Vaccine hesitancy leads to decreases in vaccination rates and causes an increase in preventable epidemics and diseases. The aim of this study is to evaluate the attitudes of patients applying to a community pharmacy regarding vaccine hesitancy during COVID-19. Setting and Method: This study was conducted in one community pharmacy for any reason between September and December 2021, Istanbul, Turkey. The ‘‘Scale of Vaccine Hesitancy’’ (1) (consisted of 12-items) was applied to the patients face to face. Sociodemographic characteristics of the patients were recorded. The results of the questionnaire were calculated according to the scale guideline. The higher score represents the higher vaccine hesitancy. Main outcome measures: Scores obtained from the scale of vaccine hesitancy and correlation of the scores with patients’ parameters such as chronical diseases, Covid-19 disease and vaccination history. Results: Of the 43 patients 90% were female. The mean age was 37.5. Thirty-five percent of the participants had COVID-19 and 69.8% had a family history of COVID-19. About 79.1% have had the COVID-19 vaccine and 76% of those were vaccinated with BioNTech and the rest with Sinovac. The mean of the vaccine hesitancy score was calculated as 27.4 (min 12-max 50). Vaccine hesitancy score was higher for patients who were not vaccinated than who were vaccinated (41.0 vs 24.2; p \0.001). The vaccine hesitancy score was higher in patients with chronic disease (28.1), in chronic medication users (28.8), in those who had COVID-19 history (29.5), and those with a family history of COVID-19 (28.2). Cronbach alpha value of the scale is 0.846. Conclusion: It was determined that unvaccinated patients had higher vaccine hesitancy scores. In addition, vaccine hesitancy score was higher in the patients with chronic disease and who had COVID-19. It is very important to have a high rate of vaccination, especially in a pandemic or life-threatening disease. Therefore, educating and relieving patients can be an important step in overcoming this problem. As pharmacists, the closest position to patients, we have a great responsibility in order to change the perspective on vaccination. References: 1. Kılınc¸arslan MG, Sarıgu¨l B, Toraman C¸, S¸ ahin EM. Development of valid and reliable Scale of Vaccine Hesitancy in Turkish language. Konuralp Medical Journal. 2020;12(3):420–429. doi: 10. 18521/ktd.693711 Disclosure of Interest: None Declared.
  • Thumbnail Image
    PublicationOpen Access
    Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease
    (W B SAUNDERS CO LTD, 2016-11) RABUŞ, ŞULE; Apikoglu-Rabus, Sule; Yesilyaprak, Gozde; Izzettin, Fikret Vehbi
    Background: Asthma and chronic obstructive pulmonary disease are preventable and treatable chronic airway diseases with high incidence and prevalence. Pharmacists and clinical pharmacy based pharmaceutical care services have positive impact on therapy outcomes. Objective: The aim of this study is to describe drug related problems in a cohort of patients with asthma and chronic obstructive pulmonary disease and to assess interventions provided by the pharmacist to address these problems in a community pharmacy. Method: Study population consisted of patients with asthma and chronic obstructive pulmonary disease older than 18 years who visited the study pharmacy during the pre-determined six-month period. The patients whose disease control states were not fully controlled were included in our study for further steps. On the first interview, present and potential drug related problems were addressed, interventions were provided. Follow-up interviews were held one month and two months later than the first interview. Results: For the 44 patients with asthma, 59 drug-related problems and 134 causes for these problems were identified. Eighty-four interventions were made to resolve the problems; and 54.2% of the problems were resolved. For the 37 patients with chronic obstructive pulmonary disease, 60 drug-related problems and 128 causes for these problems were identified. Ninety-five interventions were made to resolve the problems; and 63.3% of the problems were resolved. Conclusion: Pharmacists taking part in therapy and management of asthma and chronic obstructive pulmonary disease can help patients be more educated about their disease and medications; and improve disease control and therapy outcomes. (C) 2016 Elsevier Ltd. All rights reserved.